These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6837331)

  • 1. Prevalence of iron overload in central Sweden.
    Olsson KS; Ritter B; Rosén U; Heedman PA; Staugård F
    Acta Med Scand; 1983; 213(2):145-50. PubMed ID: 6837331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for iron overload using transferrin saturation.
    Olsson KS; Eriksson K; Ritter B; Heedman PA
    Acta Med Scand; 1984; 215(2):105-12. PubMed ID: 6702489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for iron overload in the Turkish population.
    Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
    Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
    Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK
    Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of iron fortification of the diet on clinical iron overload in the general population.
    Olsson KS; Säfwenberg J; Ritter B
    Ann N Y Acad Sci; 1988; 526():290-300. PubMed ID: 3164602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hemochromatosis among first-time and repeat blood donors in Norway.
    Bell H; Thordal C; Raknerud N; Hansen T; Bosnes V; Halvorsen R; Heier HE; Try K; Leivestad T; Thomassen Y
    J Hepatol; 1997 Feb; 26(2):272-9. PubMed ID: 9059946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis.
    Mohler DN; Wheby MS
    Am J Med Sci; 1986 Nov; 292(5):320-4. PubMed ID: 3777017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany.
    Niederau C; Niederau CM; Lange S; Littauer A; Abdel-Jalil N; Maurer M; Häussinger D; Strohmeyer G
    Ann Intern Med; 1998 Mar; 128(5):337-45. PubMed ID: 9490593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of withdrawal of food iron fortification in Sweden as studied with phlebotomy in subjects with genetic hemochromatosis.
    Olsson KS; Väisänen M; Konar J; Bruce A
    Eur J Clin Nutr; 1997 Nov; 51(11):782-6. PubMed ID: 9368814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.
    Edwards CQ; Griffen LM; Goldgar D; Drummond C; Skolnick MH; Kushner JP
    N Engl J Med; 1988 May; 318(21):1355-62. PubMed ID: 3367936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HLA linked iron loading gene in an Afrikaner population.
    Meyer TE; Ballot D; Bothwell TH; Green A; Derman DP; Baynes RD; Jenkins T; Jooste PL; du Toit ED; Jacobs PJ
    J Med Genet; 1987 Jun; 24(6):348-56. PubMed ID: 2886665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and phenotypic expression of hemochromatosis in Canadians.
    Borwein ST; Ghent CN; Flanagan PR; Chamberlain MJ; Valberg LS
    Clin Invest Med; 1983; 6(3):171-9. PubMed ID: 6652983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron deficiency and iron overload in Swedish male adolescents.
    Olsson KS; Marsell R; Ritter B; Olander B; Akerblom A; Ostergård H; Larsson O
    J Intern Med; 1995 Feb; 237(2):187-94. PubMed ID: 7852922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.
    Bulaj ZJ; Griffen LM; Jorde LB; Edwards CQ; Kushner JP
    N Engl J Med; 1996 Dec; 335(24):1799-805. PubMed ID: 8943161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.